Search alternatives:
linear decrease » linear increase (Expand Search)
lower decrease » larger decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
linear decrease » linear increase (Expand Search)
lower decrease » larger decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
4861
-
4862
-
4863
Probability of Cost-Effectiveness Across CET.
Published 2025“…When the CET was relaxed to 0.90 times GDP per capita (US$11,284.476), the probability of cost-effectiveness for AOM after a 40% price reduction rose to 85.10%. Scenario analyses conducted over a time horizon extending from 10 to 30 years showed that the ICER decreased significantly with longer follow-up, gradually approaching the 0.51GDP threshold and remaining below the 0.90 GDP threshold throughout the analysis.…”
-
4864
Base-case analysis.
Published 2025“…When the CET was relaxed to 0.90 times GDP per capita (US$11,284.476), the probability of cost-effectiveness for AOM after a 40% price reduction rose to 85.10%. Scenario analyses conducted over a time horizon extending from 10 to 30 years showed that the ICER decreased significantly with longer follow-up, gradually approaching the 0.51GDP threshold and remaining below the 0.90 GDP threshold throughout the analysis.…”
-
4865
-
4866
-
4867
The original plotting data.
Published 2024“…<div><p>Background</p><p>Glaucoma, characterized by a high incidence and significant ocular harm, has been elucidated through various mechanisms. …”
-
4868
Background characteristics of study participants.
Published 2025“…</p><p>Conclusion</p><p>Symptoms vary in onset, severity, and pattern among individuals, significantly impacting their quality of life. Nutritional support is a pressing need for cancer patients. …”
-
4869
Dataset.
Published 2025“…</p><p>Conclusion</p><p>Symptoms vary in onset, severity, and pattern among individuals, significantly impacting their quality of life. Nutritional support is a pressing need for cancer patients. …”
-
4870
-
4871
-
4872
Summary of codes generated from MAXQDA software.
Published 2025“…</p><p>Conclusion</p><p>Symptoms vary in onset, severity, and pattern among individuals, significantly impacting their quality of life. Nutritional support is a pressing need for cancer patients. …”
-
4873
Fabrication of Ionic Supramolecular Oleogel Lubricants Enhanced with Liquid Metal Nanodroplets for Superior Tribological Performance
Published 2024“…Compared to the base oil PAO10, the coefficient of friction (COF) for both GLM@IGel-1 and GLM@IGel-2 decreased significantly from 0.192 to 0.097, while the wear volume dropped from 100.10 × 10<sup>4</sup> μm<sup>3</sup> to 13.28 × 10<sup>4</sup> μm<sup>3</sup> for GLM@IGel-1, and to 9.69 × 10<sup>4</sup> μm<sup>3</sup> for GLM@IGel-2. …”
-
4874
Schematic presentation of themes and categories.
Published 2025“…</p><p>Conclusion</p><p>Symptoms vary in onset, severity, and pattern among individuals, significantly impacting their quality of life. Nutritional support is a pressing need for cancer patients. …”
-
4875
-
4876
The raw data for Fig 4.
Published 2025“…Luciferase assay and human and mouse brain multi-omics data show that, during the differentiation of OL precursor cells (OPCs) into OLs, the enhancer activity of Sox10-E1 does not change while that of Sox10-E2 decreases significantly. Chromatin interaction data indicate that the two <i>Sox10</i> enhancers lie close to the border of the <i>Sox10</i> topologically associating domain (TAD). …”
-
4877
The raw data for S2 Fig.
Published 2025“…Luciferase assay and human and mouse brain multi-omics data show that, during the differentiation of OL precursor cells (OPCs) into OLs, the enhancer activity of Sox10-E1 does not change while that of Sox10-E2 decreases significantly. Chromatin interaction data indicate that the two <i>Sox10</i> enhancers lie close to the border of the <i>Sox10</i> topologically associating domain (TAD). …”
-
4878
-
4879
The raw data for Fig 6.
Published 2025“…Luciferase assay and human and mouse brain multi-omics data show that, during the differentiation of OL precursor cells (OPCs) into OLs, the enhancer activity of Sox10-E1 does not change while that of Sox10-E2 decreases significantly. Chromatin interaction data indicate that the two <i>Sox10</i> enhancers lie close to the border of the <i>Sox10</i> topologically associating domain (TAD). …”
-
4880
The raw data for S4 Fig.
Published 2025“…Luciferase assay and human and mouse brain multi-omics data show that, during the differentiation of OL precursor cells (OPCs) into OLs, the enhancer activity of Sox10-E1 does not change while that of Sox10-E2 decreases significantly. Chromatin interaction data indicate that the two <i>Sox10</i> enhancers lie close to the border of the <i>Sox10</i> topologically associating domain (TAD). …”